Design Therapeutics
Cheryl De Hoyos has worked in various roles since 2006. Cheryl began as a Teaching Assistant/Lecturer at San Diego State University in 2006. In 2009, they became a Research Associate at Isis Pharmaceuticals, and a Senior Research Associate at Ionis Pharmaceuticals, Inc. In 2021, they began their current role as Laboratory Operations Manager at Design Therapeutics.
Cheryl De Hoyos earned their Masters degree in Chemistry and Biochemistry from San Diego State University between 2006 and 2008.
Design Therapeutics
1 followers
Design Therapeutics is pioneering novel small-molecule therapeutic candidates, called gene targeted chimeras (GeneTACs™), designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.